Application accompanying data collection in the case of market access for several active substances in a class: IQWiG presents a concept

27 May 2022 - The institute recommends platform studies under a master's protocol. ...

Read more →

HTA in the European Union: osteoporosis screening without proof of benefit

16 September 2019 - For the first time, an IQWiG team is in charge of assessing health technology for the ...

Read more →